| 80.04 -10.4 (-11.5%) | 12-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 103.8 |
1-year : | 116.21 |
| Resists | First : | 88.87 |
Second : | 99.5 |
| Pivot price | 90.97 |
|||
| Supports | First : | 71.68 |
Second : | 59.63 |
| MAs | MA(5) : | 88.29 |
MA(20) : | 91.54 |
| MA(100) : | 74.56  |
MA(250) : | 0 | |
| MACD | MACD : | 0.1 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 21.5 |
D(3) : | 23.7 |
| RSI | RSI(14): 33.5 |
|||
| 52-week | High : | 99.5 | Low : | 30.81 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ IRON ] has closed below the lower bollinger band by 32.7%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 42.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 92.11 - 92.55 | 92.55 - 93 |
| Low: | 70.63 - 71.08 | 71.08 - 71.52 |
| Close: | 79.12 - 79.91 | 79.91 - 80.69 |
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Sat, 20 Dec 2025
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Fri, 19 Dec 2025
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Fri, 19 Dec 2025
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Fri, 19 Dec 2025
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
Fri, 19 Dec 2025
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 38 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 7.8 (%) |
| Held by Institutions | 94.2 (%) |
| Shares Short | 2,590 (K) |
| Shares Short P.Month | 2,870 (K) |
| EPS | -5.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.37 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -22.7 % |
| Return on Equity (ttm) | -34.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -5.39 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -165 (M) |
| Levered Free Cash Flow | -107 (M) |
| PE Ratio | -14.91 |
| PEG Ratio | 0 |
| Price to Book value | 4.88 |
| Price to Sales | 0 |
| Price to Cash Flow | -18.35 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|